• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 2.25/15; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 2.25/15; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 419113
Device Problems Failure to Advance (2524); Material Deformation (2976)
Patient Problem Insufficient Information (4580)
Event Date 04/02/2024
Event Type  malfunction  
Manufacturer Narrative
Combination product: yes.Neither the affected product nor the angiographic material was returned.Therefore, no technical investigation on the subject could be performed.The production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.Review of the production documentation confirmed that the device was manufactured according to specifications and passed all in-process and final inspections.During final inspection, every stent system undergoes visual inspection to ensure correct stent embedding and homogeneous crimping of the stent.Further, the stent outer diameter is verified to 100 percent.It should be noted that the ifu advice the user to pre-dilate the target lesion.Based on the conducted investigations, no material or manufacturing related root cause could be determined.It should be noted that the ifu advice the user to pre-dilate the target lesion.
 
Event Description
The orsiro mission drug-eluting stent system was selected for treatment of a mildly calcified lesion (stenosis degree: 50 percent) in the mildly tortuous part of the medial lad.Pre-dilatation was not performed.In a first step, an xience des was implanted in the medial lad number 7, after which the flow became poor.The complaint stent system was advanced towards the target lesion in the medial lad number 8, but the device got caught before reaching the lesion and was removed from the patients body.A stent deformation was confirmed outside of the patient.Eventually, the physician did not use a new stent and completed the procedure.Patient was discharged home.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO MISSION 2.25/15
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key19168475
MDR Text Key341479746
Report Number1028232-2024-02212
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier07640130441736
UDI-Public(01)07640130441736(17)2404
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility,Company Representative,Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/23/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/25/2024
Device Model Number419113
Device Catalogue NumberSEE MODEL NO.
Device Lot Number04220642
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/23/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/26/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-